Rprowazekigmmsmtser
A blood test that detects IgM antibodies against Rickettsia prowazekii, the bacteria that causes epidemic typhus.
{"Detects IgM antibodies indicating recent or current infection with epidemic typhus","Requires a blood sample drawn from a vein in your arm","Positive results suggest recent exposure to Rickettsia prowazekii bacteria"}
Key facts at a glance
- LOINC
- 108869-9
- Short code
- RPROW-ABM
- Synonyms
- R prowazek IgM Msmt Ser
- Category
- cardiac
- Sample
- serum
- Container
- Serum Separator Tube (SST) or Plain Red Top Tube
- Units
- N/A
- Ref low
- 1
- Ref high
- 1.5
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–120 years
- Method
- Enzyme Immunoassay (EIA) / Immunofluorescence Assay (IFA)
- CPT
- 86757
- SNOMED
- 122441009
- Specimen volume
- 1.0-2.0 mL of serum
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 5-7 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 50
- Lipemia max
- 100
- Icterus max
- 20
- TAT
- 24–72 hours
- Order
- routine
What is this test?
The Rickettsia prowazekii IgM Antibody test is a blood test that looks for IgM antibodies in your blood. IgM antibodies are the first type of antibodies your immune system produces when fighting a new infection. This test specifically checks for antibodies against Rickettsia prowazekii, the bacteria that causes epidemic typhus (also known as louse-borne typhus).
Why might I need this test?
Your healthcare provider may order this test if you have symptoms of epidemic typhus, especially if you have been in areas where the disease is common or have been exposed to body lice. Symptoms of epidemic typhus include high fever (often 104°F or higher), severe headache, rash, muscle pain, and confusion. The test helps confirm whether your symptoms are caused by a recent Rickettsia prowazekii infection.
How is the test performed?
A healthcare professional will draw a small blood sample from a vein in your arm using a needle. The blood will be collected in a tube and sent to a laboratory for analysis. The laboratory will test your blood to detect the presence and quantity of IgM antibodies specific to Rickettsia prowazekii.
What do the results mean?
A positive IgM result indicates that you have a recent or current infection with Rickettsia prowazekii. A negative result means no IgM antibodies were detected, which could mean you do not have the infection, or the infection is too early for antibodies to be detected. Your healthcare provider will interpret your results along with your symptoms and other test findings.
Reference range
Negative: <1:64 titer or <1.0 Index; Equivocal: 1:64 titer or 1.0-1.5 Index; Positive: >1:64 titer or >1.5 IndexN/A
No special preparation required. Patient does not need to fast before sample collection. Inform laboratory of any recent infections, travel history, or exposure to louse-infested environments.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Is fasting required before this test?
How long does it take to get results?
What is epidemic typhus?
How is epidemic typhus treated?
Can I get epidemic typhus more than once?
Sources
- 1
- 2May Clinic - TyphusSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 14, 2026. · Read our editorial policy